Skip to main content
Figure 2 | Diagnostic Pathology

Figure 2

From: Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer

Figure 2

Kaplan-Meier estimates of the prognostic impact of KRAS mutation status on survival from ovarian cancer in the full cohort and according to differentiation grade and clinical stage. Kaplan-Meier analysis of ovarian cancer specific survival according to KRAS mutation status (A) in the full cohort, (B) in tumours of high-intermediate and (C) poor differentlation grade, in (D) FIGO Stage I-II tumours and (E) FIGO Stage III-IV tumours.

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us